BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22356890)

  • 21. Effect of chronic cocaine treatment on mu- and delta-opioid receptor mRNA levels in dopaminergically innervated brain regions.
    Azaryan AV; Coughlin LJ; Búzás B; Clock BJ; Cox BM
    J Neurochem; 1996 Feb; 66(2):443-8. PubMed ID: 8592112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pharmacology of the opioid receptors.
    Satoh M; Minami M
    Pharmacol Ther; 1995; 68(3):343-64. PubMed ID: 8788562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABA
    Li G; Nieman AN; Mian MY; Zahn NM; Mikulsky BN; Poe MM; Methuku KR; Liu Y; Cook JM; Stafford DC; Arnold LA
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32854311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic nicotine-induced changes in gene expression of delta and kappa-opioid receptors and their endogenous ligands in the mesocorticolimbic system of the rat.
    Ugur M; Kaya E; Gozen O; Koylu EO; Kanit L; Keser A; Balkan B
    Synapse; 2017 Sep; 71(9):. PubMed ID: 28509375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia.
    Mennicken F; Zhang J; Hoffert C; Ahmad S; Beaudet A; O'Donnell D
    J Comp Neurol; 2003 Oct; 465(3):349-60. PubMed ID: 12966560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.
    Martin M; Matifas A; Maldonado R; Kieffer BL
    Eur J Neurosci; 2003 Feb; 17(4):701-8. PubMed ID: 12603260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning of opioid receptors in common carp (Cyprinus carpio L.) and their involvement in regulation of stress and immune response.
    Chadzinska M; Hermsen T; Savelkoul HF; Verburg-van Kemenade BM
    Brain Behav Immun; 2009 Feb; 23(2):257-66. PubMed ID: 18977430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the μ, κ, and δ-opioid receptors and tyrosine hydroxylase in MN9D cells.
    Tian P; Shi W; Liu J; Wang J; Ma C; Qi Q; Cong B; Li Y
    Int J Clin Exp Pathol; 2015; 8(5):4863-8. PubMed ID: 26191179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in kappa opioid receptor inhibition of latent postoperative pain sensitization in dorsal horn.
    Custodio-Patsey L; Donahue RR; Fu W; Lambert J; Smith BN; Taylor BK
    Neuropharmacology; 2020 Feb; 163():107726. PubMed ID: 31351975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors.
    Falcon E; Browne CA; Leon RM; Fleites VC; Sweeney R; Kirby LG; Lucki I
    Neuropsychopharmacology; 2016 Aug; 41(9):2344-51. PubMed ID: 26979295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abundant expression of mu and delta opioid receptor mRNA and protein in the cerebellum of the fetal, neonatal, and adult rat.
    Mrkusich EM; Kivell BM; Miller JH; Day DJ
    Brain Res Dev Brain Res; 2004 Feb; 148(2):213-22. PubMed ID: 14766199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-Time Quantitative Reverse Transcription PCR for Detection of Opioid Receptors in Immune Cells.
    Celik MÖ; Labuz D; Machelska H
    Methods Mol Biol; 2021; 2201():83-95. PubMed ID: 32975791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.
    Bilsky EJ; Wang T; Lai J; Porreca F
    Neurosci Lett; 1996 Dec; 220(3):155-8. PubMed ID: 8994216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute stimulation of brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation.
    Tudurí E; Beiroa D; Stegbauer J; Fernø J; López M; Diéguez C; Nogueiras R
    Neuropharmacology; 2016 Nov; 110(Pt A):322-332. PubMed ID: 27511839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid receptors in the human cerebellum: evidence from [11C]diprenorphine PET, mRNA expression and autoradiography.
    Schadrack J; Willoch F; Platzer S; Bartenstein P; Mahal B; Dworzak D; Wester HJ; Zieglgänsberger W; Tölle TR
    Neuroreport; 1999 Feb; 10(3):619-24. PubMed ID: 10208600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term cognitive enrichment affects opioid receptor expression in the amygdala of domestic pigs.
    Kalbe C; Puppe B
    Genes Brain Behav; 2010 Feb; 9(1):75-83. PubMed ID: 19804558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats.
    Beland B; Fitzgerald M
    Pain; 2001 Feb; 90(1-2):143-50. PubMed ID: 11166980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite alterations of NPFF1 and NPFF2 neuropeptide FF receptor density in the triple MOR/DOR/KOR-opioid receptor knockout mouse brains.
    Gouardères C; Kieffer BL; Zajac JM
    J Chem Neuroanat; 2004 May; 27(2):119-28. PubMed ID: 15121216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
    Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation.
    Puehler W; Rittner HL; Mousa SA; Brack A; Krause H; Stein C; Schäfer M
    Neuroscience; 2006 Aug; 141(2):989-998. PubMed ID: 16782281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.